EphA2 T-cell epitope are provided herein. The epitopes include peptides corresponding to specific fragments of human EphA2 protein containing one or more T-cell epitopes, and conservative derivatives thereof. The EphA2 T-cell epitopes are useful in an assay, such as an ELISPOT assay, that may be used to determine and/or quantify a patient's immune responsiveness to EphA2. The epitopes also are useful in methods of modulating a patient's immune reactivity to EphA2, which has substantial utility as a treatment for cancers that overexpress EphA2, such as renal cell carcinoma (RCC). The EphA2 epitopes also can be used to vaccinate a patient against EphA2, by in vivo or ex vivo methods.

 
Web www.patentalert.com

< Polynucleotide encoding autoantigens associated with endometriosis

< Anti-angiogenic polypeptides

> Novel 4-oxoquinoline compound and use thereof as HIV integrase inhibitor

> Process for the preparation of azithromycin monohydrate isopropanol clathrate

~ 00234